TOPISCHE ZUSAMMENSETZUNG

European patent · EP3576716 · In force

Register entry

Publication number
EP3576716
Application number
EP18703825
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 30, 2018
Published
Dec 11, 2019
Granted
Jun 21, 2023
Protection ends at the latest
Jan 29, 2038
Next annual fee due
Jan 31, 2027
IPC classes
A61K 31/69 (2006.01)
Priority
GB 201701583 31.01.2017
PCT application
PCT/GB2018/050263 30.01.2018
PCT publication
WO2018/142117 09.08.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  5. Aug 8, 2023

    Agent entered

    Representative
    Kirker & Cie SA, Rue de Genève 122, CP 153, 1226 Genève-Thônex

    Published in Swissreg on 08.08.2023

  6. Jun 21, 2023

    Granted

    Published in Swissreg on 21.06.2023

Parties

Holder

MC2 Therapeutics Limited

1A Guildford Business Park, Guildford GU2 8XG, GB

Agent

Kirker & Cie SA

Rue de Genève 122 CP 153, 1226 Genève-Thônex

Inventor

GEORGIOU, Michelle

Leatherhead Surrey KT22 7EP, GB

CRUTCHLEY, Nigel

Leatherhead Surrey KT22 7EP, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.